Aripiprazole in a Therapy-resistant Patient with Borderline Personality and Post-Traumatic Stress Disorder

References

• 1 Grootens KP, Verkes RJ. Emerging evidence for the use of atypical antipsychotics in borderline personality disorder.  Pharmacopsychiatry. 2005;  38 20-23
• 2 Mosbascher A, Mosbascher J, Schlemper V, Winterer G, Malevani J. Aripiprazole pharmacotherapy of borderline personality disorder.  Pharmacopsychiatry. 2006;  39 111-112
• 3 Nickel MK, Muehlbacher M, Nickel C, Kettler C, Pedrosa Gil F, Bachler E, Buschmann W, Rother N, Fartacek R. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.  Am J Psychiatry. 2006;  163 833-838
• 4 Worthington III JJ, Kinrys G, Wygant LE, Pollack MH. Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients.  Int Clin Psychopharmacol. 2005;  20 9-11
• 5 Lambert MT. Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans.  Int Clin Psychopharmacol. 2006;  21 185-187
• 6 Saha AR, Ali M, Ingenito GG, Wiber R, Luo X, Bramer S. Safety and tolerability of aripiprazole at doses higher than 30 mg.  Int J Neuropsychopharmacol. 2002;  5 ((Suppl. 1)) 185

Correspondence